# Page 1
To grant administrative approval for procurement of drugs/ surgicals, testing kits etc. under COVID-19 measures by Haffkine Corporation.
The Government of Maharashtra
Department of Medical Education and Drugs
GOVERNMENT DECISION NO.: COVID-2021/ PR No.211/ ADMINISTRATION-2
Gokuldas Tejpal Hospital
The 9th Floor, Mantralaya, Mumbai
The date is March 31, 2022.
(1) Government Resolution, Finance Division No: 2013/ No. 30/13/ Regulations, D.
17.04.2015 2) Government Decision, Department of Medical Education and Pharmaceuticals No.: SANKIN 2014/ PR No. 178/ Administration-2, D. 06.02.2015 3) Commissioner, Directorate of Medical Education and Research, Mumbai vide letter No. Medicines/ Essential and Life saving drugs/ Dosage/ 3646/2022, Dy.
31.03.2022.
4) Government Resolution No.: Dated 30.07.2021.
5) Government Resolution No.: Dated 13.10.2021.
6) Government Decision, Medical Education and Pharmaceuticals Department No: COVID 2021/ No. 177/ Administration-2, D. 09.08.2021
Preamble: Under the Objectives of the Directorate of Medical Education and Research under heading 2210-3314 (21) Materials and Supplies, for procurement of drugs, surgicals and allied items required by the institutions under the Directorate for prevention of COVID-19 and Mucormycosis, in the Monsoon Session of July, 2021, an amount of Rs. A sum of Rs. 180.00 crore has been sanctioned. In accordance with the total sanctioned funds through this Supplementary Demand, the Government vide Reference No. 4, 5 and 6 respectively. 98.93 crore, Rs. 45.78 crore and Rs.
Administrative approval was given to Haffkine Corporation for the purchase of medicines, surgical materials, test kits worth Rs. 35.13 crore.
According to the purchase order, administrative sanction and approval rates, the Haffkine Corporation has spent a total of Rs. 151.10 crore has been submitted to Directorate General of Health Services (DGHS) and they are in possession of the proforma invoice for any matter as per the administrative approval of COVID-19
# Page 2
GOVERNMENT DECISION NO.: COVID-2021/ PR No.211/ ADMINISTRATION-2, D. As of March 31, 2022
Haffkine Corporation vide letter dated 30.03.2022 has informed that there is no pendency.
Accordingly, in the financial year 2021-2022, under the COVID-19 Measures, Reference No. 4, 5 and 6 respectively. 98.93 crore, Rs. 45.78 crore and Rs. 35.13 crore out of administrative sanction of Rs. Since the amount saved is Rs. 28.1652 crore, the Government was considering granting administrative approval to Haffkine Corporation to procure medicines, surgicals and related items required by the institutions under the Directorate from the amount of the said savings.
Government Decision Under COVID-19 Measures for the Financial Year 2021-2022 Reference No. 4, 5 and 6 respectively. 98.93 crore, Rs. 45.78 crore and Rs. 35.13 crore out of administrative sanction of Rs. Out of the total savings of Rs. 28.1652 crore, Rs. 3 In the list attached with the above letter dated 31.03.2022, the Haffkine Corporation is required to purchase 32 medicines, surgicals and related items at a cost of Rs. Administrative Sanction is being accorded for an amount of Rs. 28.1652 crore.
2. While procuring these items from Haffkine Corporation vide Reference No. The said administrative approval is being granted subject to the terms and conditions of the Government Resolution dated 30.07.2021.
The Commissioner, Directorate of Medical Education and Research, Mumbai shall be solely responsible for ensuring that the requirements of the said drugs, surgicals and other items, as well as the said procurement, are as per the prevailing rules.
4. The expenditure for the purchase of the aforesaid items shall be met from the following head of accounts of the Director, Medical Education and Research, Mumbai.
Demand No-S-1
2210- Medical Services and Public Health
01- Civil Health Service
1- Management and Administration.
Director of Medical Education and Research, Mumbai.
(22103314)
21- Supplies and Supplies
Page 2 of 3
# Page 3
GOVERNMENT DECISION NO.: COVID-2021/ PR No.211/ ADMINISTRATION-2, D. As of March 31, 2022
Government Decision, Department of Medical Education and Pharmaceuticals No. 2014/ No. 178/ Administration-2, D. The said rule shall be issued under the authority vested in the Administrative Department as per Rule No. 169 of the Financial Powers Rules Book Part-I, Sub-Division-II, Roll No. 45 mentioned in the return A along with 06.02.2015.